Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-01-02
2007-01-02
Murphy, Joseph (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S006120, C435S320100, C435S325000, C530S350000, C536S023100
Reexamination Certificate
active
10119624
ABSTRACT:
The present invention provides nucleic acid and polypeptide sequences describing a novel isoform of the α2δ subunit of a voltage gated calcium channel, herein named as α2δ-4. The isolated nucleic acid or polypeptide molecule of the invention can be used in diagnosing and treating a disease or disorder associated with a defective α2δ-4 subunit, such as seizure-related syndromes, anxiety, multiple sclerosis, and the like.
REFERENCES:
patent: 6013474 (2000-01-01), Ellis et al.
patent: WO 96/39512 (1996-12-01), None
patent: WO 00/20450 (2000-04-01), None
patent: WO 01/08635 (2001-02-01), None
patent: WO 01/19870 (2001-03-01), None
Klugbauer N et al. Molecular diversity of the calcium channel alpha2delta subunit. J Neurosci. Jan. 15, 1999;19(2):684-91.
Yan et al., Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290: 523-527, 2000.
Mickle JE et al. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am. May 2000;84(3):597-607.
Voet et al. Biochemistry. 1990. John Wiley & Sons, Inc. pp. 126-128 and 228-234.
Eck & Wilson in Goodman & Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition, McGraw-Hill New York, 1996.
U.S. Appl. No. 09/833,222, Qin et al.
Backonja, M. et al “Gabapetin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus,” JAMA. 1998, 280(21) 1831-1836.
Bean, B P, “Classes of Calcium Channels in Vertebrate Cells,” Annual Rev. Physiol 1989. 51:367-84.
Bertolino. M, et al. “The Central Role of Voltage-Activated and Receptor-Operated Calcium Channels in Neuronal Cells,” Annunal Rev. Pharmacol. Toxicol. Annu. 1992. 32:399-421.
Catterall. W A. “Structure and Regulation of Voltage-Gated Ca Channels,” Annu Rev Cell Dev Biol 2000. 16:521-55.
Catterall. W.A., “Structure and Function of voltage-gated ion channels,” Trends in Neurosciences. 1993. 16.500-506.
Catterall. W.A., “Structure and Function of Voltage-Sensitive Ion Channels,” Science. 1988. 242:50-61.
Daniel. S., et al., “Screening for Potassium Channel Modulators by a High Through-Put 86 Rubidium Efflux Assay in a 96-Well Microtiter Plate,” Journal of Pharmacol Methods. 1991. 25:185-193.
Dejongh. K. S. et al., “Subunits of Purified Calcium Channels,” Journal of Biological Chemistry. 1990. 265(25) 14738-14741.
Ellis, S. B., et al., “Sequence and Expression of mRNAs Encoding the α2Subunits of a DHP-sensitive Calcium Channel,” Science, 1988, 241:1661-1664.
Erfurth, A., et al., “An open label study of gabapentin in the treatment of acute mania,” Journal of Psychiatric Research 1998 32:261-264.
Ertel, E. A., et al., “Nomenclature of Voltage-Gated Calcium Channels,” Neuron. 2000. 25 533-535.
Evidente, V.G., et al., “Effective Treatment of Orthostatic Tremor With Gabapentin,” Movement Disorders, 1998. 13(5)829-831.
Gee. N. S., et al., The Novel Anticonvulsant Drug, Gagapentin (Neurontin). Binds to the α2Ō Subunit of a Calcium Channel, Journal of Biological Chemistry, 1996, 271(10):5768-5776.
Gaild, B., et al., “Identification of the alternative spliced form of the α2/Ō subunit of voltage sensitive Ca2channels expressed in PC12 cells,” Neuroscience Letters, 1995, 193:157-160.
Greenburg, D. A., “Calcium Channels in Neurological Disease,” Annuals of Neurology, 1997, 42:275-282.
Gurnett, C.A., et al., “Dual Function of the Voltage-Dependent Ca2Channel α2Ō Subunit in Current Stimulation and Subunit Interaction,” Neuron. 1996. 16:431-440.
Holevinsky, K.O., et al., “ATP-sensitive K Channel Opener Acts as a Potent C1 Channel Inhibitor in Vascular Smooth Muscle Cells,” J. Membrane Biol. 1994, 137:59-70.
Horowitz, B., et al., “Synthesis and Assembly of Functional Mammalian Na,K-ATPase in Yeast,” Journal of Biological Chemistry, 1990, 265(8)4189-4192.
Hosey, M.M., et al., “L-Type Calcium Channels in Cardiac and Skeletal Muscle,” Ann NY Acad Sci, 1990, 560:27-38.
Jacobson, M.A., et al., “Expression and secretion of biologically active echistatinSaccharomyces cerevisiae,” Gene 1989, 85:511-516.
Jay, S.D., et al., “Primary Structure of the γ Subunit of the DHP-Sensitive Calcium Channel from Skeletal Muscle,” Science, 1990, 248:490-92.
Jay, S.D., et al., “Structural Characterization of the Dihydropyridine-sensitive Calcium Channel α2-Subunit and the Associated ō Peptides,” Journal of Biological Chemistry: 1991, 266(5)3287-3293.
Kaufman, R.J., et al., Amplification and Expression of Sequences Contransfected with a Modular Dihydrofolate Reductase Complementary DNA Gene, 1982, J. Mol. Biol. 159:601-621.
Kok, K., et al., “Deletions of the Short Arm of Chromosome 3 in Solid Tumors and the Search for suppressor Genes,” Advances in Cancer Research, 1997, 71:27-92.
Mazzini, L., et al., “The natural history and the effects of gabapentin in amyotrophic lateral sclerosis,” Journal of the Neurological Sciences, 1998, 160:S57-S63.
Metz, Luanne, “Multiple Sclerosis: Symptomatic Therapies,” Seminars in Neurology, 1998 18(3) 389-395.
Olson, W.L., et al., “Gabapentin for Parkinsonism A Double-Blind, Placebo-controlled, Crossover Trial,” American Journal of Medicine, 1997, 102(1)60-6).
Qin, N. et al., “Modulation of human neuronal α1E-type calcium channel by α2ō-subunit,” American J Physiol Cell Physiol, 1998 274 C1324-31.
Randall, A., et al., “Pharmacological Dissection of Multiple Types of Co2xChannel Currents in Rat Cerebeliar Granuie Neurons,” Journal of Neuroscience, 1995, 15 2995-3012.
Riehl-Bellion. N. et al., “Purification and Biochemical Characterization of Recombinant Hirudin Produced bySaccharomyces cerevisiae,” Biochemistry, 1989, 28 2941-2949.
Rinas, U. et al., “Characterization of Recombinant Factor Xllla Produced inSaccharomyces cerevisiae,” Biotechnology 1990, 8:543-546.
Rock, D. et al., “Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons,” Epilepsy Research, 1993, 16 89-98.
Rorsmanm, P., et al., “Ion Channels, Electrical Activity and Insulin Secretion” Diabetes Metabolisme, 1994, 20: 138-145.
Rowbotham, M. et al., “Gabapentin for the Treatment of Postherpetic Neuralgia,” JAMA, 1998, 280(1): 1837-1942.
Ruth, P., et al., Primary Structure of the β Subunit of the DHP-Sensitive Calcium Channel from Skeletal Muscle, Science, 1989, 245: 1115-1118.
Sieckevitz, M., et al., “Activation of the HIV-1 LTR by T Cell Mitogens and the Trans-Activator Protein of HTLV-1,” Science, 1987, 238:1575-1578.
Singh, L., et al., “The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions tht are reversed by D-Serine,” Psychopharmacology, 1996, 127(1)1-9.
Tanabe, T., et al., “Primary structure of the receptor for calcium channel blockers from skeletal muscle,” Nature, 1987, 328:313-318.
Terwindt, G. M., et al., “Migraine, ataxia and epilepsy: a challenging spectrum of genetically determined calcium channelopathies,” Eur Journal of Human Genetics, 1998, 64(4)297-307.
Tokumaru, H., et al., “A Calcium Channel from the Presynaptic Nerve Terminal of the Narke japonica Electric Organ Contains a Non-N-Type α2ō Subunit,” Journal of Neurochemistry, 1995, 65:831-836.
Vestergard-Bogind, B. “Single-File Diffusion through the Ca2-Activated K Channel of Human Red Cells,” 1988, 88:67-75.
Watson, W.P. et al., “The Novel Anticonvulsant Gabapentin, Protects Against Both Convulsant and Anxiogenic Aspects of the Ethanol Withdrawl Syndrome,” Neuropharmacology, 1997, 36(10) 1369-1375.
Wigler, M., et al., ȁ
Codd Ellen
Qin Ning
McCormack Myra
Murphy Joseph
Ortho-McNeil Pharmaceutical , Inc.
LandOfFree
CDNA encoding the human α2 δ4 calcium channel... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CDNA encoding the human α2 δ4 calcium channel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CDNA encoding the human α2 δ4 calcium channel... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3734344